1. Home
  2. GMAB
  3. GMAB News

Latest Genmab A/S ADS (GMAB) News on January 22, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option?
GMAB

Zacks

5 days ago

GMAB vs. QGEN: Which Stock Is the Better Value Option?

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know
GMAB

Zacks

7 days ago

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know

Are Investors Undervaluing Genmab (GMAB) Right Now?
GMAB

Zacks

8 days ago

Are Investors Undervaluing Genmab (GMAB) Right Now?

High Growth Tech Stocks To Watch In January 2025
GMAB

Simply Wall St.

15 days ago

High Growth Tech Stocks To Watch In January 2025

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GMAB

GlobeNewswire

18 days ago

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Genmab to Hold 2024 R&D Update and ASH Data Review Meeting
GMAB

GlobeNewswire

a month ago

Genmab to Hold 2024 R&D Update and ASH Data Review Meeting

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
GMAB

Business Wire

a month ago

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
GMAB

GlobeNewswire

a month ago

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

GMAB

MT Newswires

a month ago

Genmab's Potential Leukemia Treatment Shows Overall Response Rate of 61% in Phase 1/2 Trial

Exploring None's High Growth Tech Stocks With Strong Potential
GMAB

Simply Wall St.

a month ago

Exploring None's High Growth Tech Stocks With Strong Potential

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis
GMAB

Business Wire

a month ago

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
GMAB

GlobeNewswire

a month ago

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Capital Increase in Genmab as a Result of Employee Warrant Exercise
GMAB

GlobeNewswire

2 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
GMAB

GlobeNewswire

2 months ago

Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons

Why Is Genmab A/S (GMAB) Among the Best High Growth Healthcare Stocks to Invest In Now?
GMAB

Insider Monkey

2 months ago

Why Is Genmab A/S (GMAB) Among the Best High Growth Healthcare Stocks to Invest In Now?

Why Is Genmab A/S (GMAB) Among the Worst Performing Healthcare Stocks in 2024?
GMAB

Insider Monkey

2 months ago

Why Is Genmab A/S (GMAB) Among the Worst Performing Healthcare Stocks in 2024?

Genmab to Present at Citi’s Global Healthcare Conference
GMAB

GlobeNewswire

2 months ago

Genmab to Present at Citi’s Global Healthcare Conference

Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
GMAB

Insider Monkey

2 months ago

Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?

Grant of Restricted Stock Units and Warrants to Employees in Genmab
GMAB

GlobeNewswire

2 months ago

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
GMAB

Insider Monkey

2 months ago

Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now

High Growth Tech Stocks To Watch In November 2024
GMAB

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In November 2024

Genmab AS (GMAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Pipeline ...
GMAB

GuruFocus.com

2 months ago

Genmab AS (GMAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Pipeline ...

GMAB

MT Newswires

2 months ago

Genmab Shares Fall After Reporting Q3 Results

Genmab Announces Financial Results for the First Nine Months of 2024
GMAB

GlobeNewswire

3 months ago

Genmab Announces Financial Results for the First Nine Months of 2024

Genmab to Present at Jefferies London Healthcare Conference
GMAB

GlobeNewswire

3 months ago

Genmab to Present at Jefferies London Healthcare Conference

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting
GMAB

Business Wire

3 months ago

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting

Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics
GMAB

Insider Monkey

3 months ago

Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock?
GMAB

Zacks

3 months ago

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock?

Is Genmab (GMAB) Stock Undervalued Right Now?
GMAB

Zacks

3 months ago

Is Genmab (GMAB) Stock Undervalued Right Now?

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024
GMAB

GlobeNewswire

3 months ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024

Genmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge Funds
GMAB

Insider Monkey

3 months ago

Genmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge Funds

GMAB or INCY: Which Is the Better Value Stock Right Now?
GMAB

Zacks

3 months ago

GMAB or INCY: Which Is the Better Value Stock Right Now?

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround
GMAB

Zacks

3 months ago

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround

Major Shareholder Announcement
GMAB

GlobeNewswire

4 months ago

Major Shareholder Announcement

Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
GMAB

Insider Monkey

4 months ago

Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?

Grant of Restricted Stock Units and Warrants to Employees in Genmab
GMAB

GlobeNewswire

4 months ago

Grant of Restricted Stock Units and Warrants to Employees in Genmab

GMAB

MT Newswires

4 months ago

Genmab Reports 'Encouraging' Data From Phase 1/2 Study of Investigational Ovarian Cancer Drug

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial
GMAB

Business Wire

4 months ago

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial

Capital Increase in Genmab as a Result of Employee Warrant Exercise
GMAB

GlobeNewswire

4 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

GMAB

MT Newswires

4 months ago

Truist Lowers Price Target on Genmab to $50 From $53, Maintains Buy Rating

Genmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
GMAB

Insider Monkey

5 months ago

Genmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers

GMAB

MT Newswires

5 months ago

HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair

Top High Growth Tech Stocks To Watch In August 2024
GMAB

Simply Wall St.

5 months ago

Top High Growth Tech Stocks To Watch In August 2024

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
GMAB

GlobeNewswire

5 months ago

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
GMAB

Zacks

5 months ago

AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use

GMAB

MT Newswires

5 months ago

Genmab, AbbVie Get Conditional European Commission Approval for Lymphoma Treatment

TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
GMAB

Business Wire

5 months ago

TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
GMAB

GlobeNewswire

5 months ago

TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

GMAB

MT Newswires

5 months ago

Genmab COO Anthony Mancini Departs; Firm Names New CTO, CCO

Genmab Announces Changes to its Executive Committee
GMAB

Business Wire

5 months ago

Genmab Announces Changes to its Executive Committee

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Capital Increase in Genmab as a Result of Employee Warrant Exercise
GMAB

GlobeNewswire

5 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

GMAB

MT Newswires

5 months ago

Genmab's Interim Q2 Earnings, Revenue Climb; Increases 2024 Revenue Guidance

Genmab Announces Financial Results for the First Half of 2024
GMAB

GlobeNewswire

5 months ago

Genmab Announces Financial Results for the First Half of 2024

Genmab Updates 2024 Financial Guidance
GMAB

GlobeNewswire

5 months ago

Genmab Updates 2024 Financial Guidance

BioNTech exits PD-L1 development with Genmab as Q2 revenues drop
GMAB

Pharmaceutical Technology

6 months ago

BioNTech exits PD-L1 development with Genmab as Q2 revenues drop

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls
GMAB

Investopedia

6 months ago

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls

Genmab Takes Full Control of Acasunlimab Development Program
GMAB

GlobeNewswire

6 months ago

Genmab Takes Full Control of Acasunlimab Development Program

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet
GMAB

Zacks

6 months ago

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet

Buy 2 Biotech Bigwigs Set to Gain on Possible Earnings Beat
GMAB

Zacks

6 months ago

Buy 2 Biotech Bigwigs Set to Gain on Possible Earnings Beat

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy
GMAB

Zacks

6 months ago

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy

GMAB vs. CSLLY: Which Stock Is the Better Value Option?
GMAB

Zacks

6 months ago

GMAB vs. CSLLY: Which Stock Is the Better Value Option?

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
GMAB

GlobeNewswire

6 months ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024

GMAB

MT Newswires

6 months ago

RBC Upgrades Genmab to Outperform From Sector Perform, Keeps Price Target at DKK2,400

GMAB or TECH: Which Is the Better Value Stock Right Now?
GMAB

Zacks

6 months ago

GMAB or TECH: Which Is the Better Value Stock Right Now?

GMAB vs. TECH: Which Stock Is the Better Value Option?
GMAB

Zacks

6 months ago

GMAB vs. TECH: Which Stock Is the Better Value Option?

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
GMAB

Zacks

7 months ago

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

GMAB

MT Newswires

7 months ago

AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment

Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma
GMAB

Business Wire

7 months ago

Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma

Completion of Share Buy-back Program
GMAB

GlobeNewswire

7 months ago

Completion of Share Buy-back Program

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
GMAB

Zacks

7 months ago

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

GMAB

MT Newswires

7 months ago

BTIG Adjusts Price Target on Genmab to $47 From $46, Maintains Buy Rating

GMAB

MT Newswires

7 months ago

Genmab Gets FDA Approval for Follicular Lymphoma Treatment

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
GMAB

Business Wire

7 months ago

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Transactions in Connection with Share Buy-back Program
GMAB

GlobeNewswire

7 months ago

Transactions in Connection with Share Buy-back Program

Capital Increase in Genmab as a Result of Employee Warrant Exercise
GMAB

GlobeNewswire

7 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Transactions in Connection with Share Buy-back Program
GMAB

GlobeNewswire

7 months ago

Transactions in Connection with Share Buy-back Program

Grant of Restricted Stock Units and Warrants to Employees in Genmab
GMAB

GlobeNewswire

7 months ago

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
GMAB

GlobeNewswire

7 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
GMAB

PR Newswire

7 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
GMAB

Business Wire

7 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
GMAB

AFP

7 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
GMAB

The Wall Street Journal

7 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

GMAB

Business Wire

7 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool
GMAB

Bloomberg

7 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
GMAB

Simply Wall St.

7 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors
GMAB

Simply Wall St.

7 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Transactions in Connection with Share Buy-back Program
GMAB

GlobeNewswire

7 months ago

Transactions in Connection with Share Buy-back Program

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
GMAB

Business Wire

7 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
GMAB

GlobeNewswire

7 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
GMAB

GlobeNewswire

7 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
GMAB

Simply Wall St.

7 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
GMAB

Reuters

7 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
GMAB

AFP

7 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
GMAB

GlobeNewswire

7 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed
GMAB

PR Newswire

7 months ago

Enduring role of 'treasuring the past' hailed

Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
GMAB

GlobeNewswire

8 months ago

Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference

GMAB

MT Newswires

8 months ago

Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating

GMAB

MT Newswires

8 months ago

Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study

Transactions in Connection with Share Buy-back Program
GMAB

GlobeNewswire

8 months ago

Transactions in Connection with Share Buy-back Program

Share on Social Networks: